Cargando…

S100A9 regulates cisplatin chemosensitivity of squamous cervical cancer cells and related mechanism

OBJECTIVE: Our previous research has shown that the expression of S100 calcium-binding protein A9 (S100A9) in tumor cells was associated with neoadjuvant chemotherapy sensitivity in cervical squamous cell carcinoma. In the present study, we altered the expression of S100A9 through infecting lentivir...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Chuchu, Lu, Ermei, Hu, Xiaoli, Cheng, Huihui, Zhang, Jian-An, Zhu, Xueqiong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6159790/ https://www.ncbi.nlm.nih.gov/pubmed/30288106 http://dx.doi.org/10.2147/CMAR.S168276

Ejemplares similares

PKM2 enhances chemosensitivity to cisplatin through interaction with the mTOR pathway in cervical cancer
por: Zhu, Haiyan, et al.
Publicado: (2016)

Molecular mechanisms of cisplatin resistance in cervical cancer
por: Zhu, Haiyan, et al.
Publicado: (2016)

METTL3 increases cisplatin chemosensitivity of cervical cancer cells via downregulation of the activity of RAGE
por: Li, Ruyi, et al.
Publicado: (2021)

Overexpression and biological function of PRDX6 in human cervical cancer
por: Hu, Xiaoli, et al.
Publicado: (2020)

Up-regulation of peroxiredoxin-1 promotes cell proliferation and metastasis and inhibits apoptosis in cervical cancer
por: Lu, Ermei, et al.
Publicado: (2020)

Up-regulation of peroxiredoxin-1 promotes cell proliferation and metastasis and inhibits apoptosis in cervical cancer: Erratum
por: Lu, Ermei, et al.
Publicado: (2022)

The effect of propofol on chemosensitivity of paclitaxel in cervical cancer cells
por: Jin, Yanshan, et al.
Publicado: (2023)

Prediction of the Mechanisms by Which Quercetin Enhances Cisplatin Action in Cervical Cancer: A Network Pharmacology Study and Experimental Validation
por: Ji, Huihui, et al.
Publicado: (2022)

In vitro platinum drug chemosensitivity of human cervical squamous cell carcinoma cell lines with intrinsic and acquired resistance to cisplatin.
por: Mellish, K. J., et al.
Publicado: (1993)

Naa10p Enhances Chemosensitivity to Cisplatin in Oral Squamous Cell Carcinoma Cells
por: Sun, Lichun, et al.
Publicado: (2021)

The role of calgranulin B gene on the biological behavior of squamous cervical cancer in vitro and in vivo
por: Zhang, Wenwen, et al.
Publicado: (2018)

The Effects of Guizhi Fuling Capsule Drug Serum on Uterine Leiomyoma Cells and Its Mechanism
por: Shen, Qi, et al.
Publicado: (2016)

Astragali radix total flavonoid synergizes cisplatin to inhibit proliferation and enhances the chemosensitivity of laryngeal squamous cell carcinoma
por: Cui, Jiajia, et al.
Publicado: (2019)

Predictive role of galectin-1 and integrin α5β1 in cisplatin-based neoadjuvant chemotherapy of bulky squamous cervical cancer
por: Zhu, Haiyan, et al.
Publicado: (2017)

eIF4E promotes tumorigenesis and modulates chemosensitivity to cisplatin in esophageal squamous cell carcinoma
por: Liu, Ting, et al.
Publicado: (2016)

Inhibition of Kpnβ1 mediated nuclear import enhances cisplatin chemosensitivity in cervical cancer
por: Chi, Ru-pin Alicia, et al.
Publicado: (2021)

Cell fate determination in cisplatin resistance and chemosensitization
por: Luong, Khanh V., et al.
Publicado: (2016)

miR-218 suppresses tumor growth and enhances the chemosensitivity of esophageal squamous cell carcinoma to cisplatin
por: Tian, Hang, et al.
Publicado: (2022)

The functional mechanism of miR-125b in gastric cancer and its effect on the chemosensitivity of cisplatin
por: Zhang, Xinyue, et al.
Publicado: (2017)

Investigating the potential mechanism of quercetin against cervical cancer
por: Chu, Man, et al.
Publicado: (2023)

Definitive extended field intensity-modulated radiotherapy and concurrent cisplatin chemosensitization in the treatment of IB2-IIIB cervical cancer
por: Zhang, Guangyu, et al.
Publicado: (2014)

Chemosensitizing and nephroprotective effect of resveratrol in cisplatin –treated animals
por: Osman, Abdel-Moneim M, et al.
Publicado: (2015)

Autophagy modulating agents as chemosensitizers for cisplatin therapy in cancer
por: Gąsiorkiewicz, Bartosz Mateusz, et al.
Publicado: (2020)

sCLU regulates cisplatin chemosensitivity of lung cancer cells in vivo
por: Ma, Guoliang, et al.
Publicado: (2015)

A PLK1 kinase inhibitor enhances the chemosensitivity of cisplatin by inducing pyroptosis in oesophageal squamous cell carcinoma
por: Wu, Mengjiao, et al.
Publicado: (2019)

Effects of NOB1 on the pathogenesis of osteosarcoma and its expression on the chemosensitivity to cisplatin
por: Luo, Leiming, et al.
Publicado: (2018)

Prognostic value of microvessel density in cervical cancer
por: Hu, Xiaoli, et al.
Publicado: (2018)

Correction: The functional mechanism of miR-125b in gastric cancer and its effect on the chemosensitivity of cisplatin
por: Zhang, Xinyue, et al.
Publicado: (2020)

MiR-132 inhibits migration and invasion and increases chemosensitivity of cisplatin-resistant oral squamous cell carcinoma cells via targeting TGF-β1
por: Chen, Liqiang, et al.
Publicado: (2020)

Correction to: Chemosensitizing and nephroprotective effect of resveratrol in cisplatin-treated animals
por: Osman, Abdel-Moneim M., et al.
Publicado: (2019)

Metabolic Phenotyping Predicts Gemcitabine and Cisplatin Chemosensitivity in Patients With Cholangiocarcinoma
por: Suksawat, Manida, et al.
Publicado: (2022)

The deacetylation of Foxk2 by Sirt1 reduces chemosensitivity to cisplatin
por: Wang, Xi‐wen, et al.
Publicado: (2021)

Enhanced Chemosensitivity by Targeting Nanog in Head and Neck Squamous Cell Carcinomas
por: Huang, Chuan-En, et al.
Publicado: (2014)

DHODH Inhibition Exerts Synergistic Therapeutic Effect with Cisplatin to Induce Ferroptosis in Cervical Cancer through Regulating mTOR Pathway
por: Jiang, Mengying, et al.
Publicado: (2023)

Establishment and genetically characterization of patient-derived xenograft models of cervical cancer
por: Zou, Shuangwei, et al.
Publicado: (2022)

The expression of S100A8/S100A9 is inducible and regulated by the Hippo/YAP pathway in squamous cell carcinomas
por: Li, Yunguang, et al.
Publicado: (2019)

Short hairpin RNA targeting Twist1 suppresses cell proliferation and improves chemosensitivity to cisplatin in HeLa human cervical cancer cells
por: ZHU, KEXIU, et al.
Publicado: (2012)

Metformin enhances the chemosensitivity of hepatocarcinoma cells to cisplatin through AMPK pathway
por: Dong, Hao, et al.
Publicado: (2017)

Pretreatment with LCK inhibitors chemosensitizes cisplatin‐resistant endometrioid ovarian tumors
por: Crean-Tate, Katie K., et al.
Publicado: (2021)

Dacomitinib improves chemosensitivity of cisplatin-resistant human ovarian cancer cells
por: Xu, Lei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3i3d52b59jlr89s5tjuuic8ih4